Parkinson’s Disease

  • Parkinson’s disease is a progressive neurodegenerative disorder affecting movement.
  • It is caused by the degeneration of dopamine-producing neurons in the substantia nigra, a part of the brain that controls movement.

Causes of Parkinson’s Disease

  1. Genetic Factors: Mutations in specific genes (e.g., LRRK2, PARK2).
  2. Environmental Factors: Exposure to toxins like pesticides and heavy metals.
  3. Age: Incidence increases with age.
  4. Gender: More common in men than in women.
Demo Ad
This is a sample ad placement!

Symptoms of Parkinson’s Disease

  1. Motor Symptoms:

    • Tremor: Shaking, often starting in one hand.
    • Bradykinesia: Slowness of movement.
    • Rigidity: Stiffness in limbs and trunk.
    • Postural Instability: Impaired balance and coordination.
  2. Non-Motor Symptoms:

    • Cognitive impairment and dementia.
    • Mood disorders: Depression and anxiety.
    • Sleep disturbances: Insomnia, REM sleep behavior disorder.
    • Autonomic dysfunction: Constipation, orthostatic hypotension, and urinary problems.

Diagnosis

  1. Clinical Evaluation: Based on medical history and neurological examination.
  2. Imaging Tests: MRI or DaTscan (dopamine transporter scan) to support the diagnosis.
  3. Response to Medication: Improvement of symptoms with dopaminergic medications supports the diagnosis.
Demo Ad
This is a sample ad placement!

Pathophysiology of Parkinson’s Disease

Pathophysiology of Parkinson’s Disease
Pathophysiology of Parkinson’s Disease
  1. Dopamine Deficiency: Degeneration of dopaminergic neurons in the substantia nigra of the brain.
  2. Lewy Bodies: Abnormal aggregates of the protein alpha-synuclein inside neurons.
  3. Basal Ganglia Dysfunction: Impaired regulation of motor activity leading to symptoms like bradykinesia, tremors, and rigidity.

Treatment 

  1. Medications:

    • Levodopa: The most effective treatment, often combined with carbidopa.
    • Dopamine Agonists: Mimic dopamine effects (e.g., pramipexole, ropinirole).
    • MAO-B Inhibitors: Prevent breakdown of brain dopamine (e.g., selegiline, rasagiline).
    • COMT Inhibitors: Prolong the effect of levodopa (e.g., entacapone).
  2. Surgical Treatment:

    • Deep brain stimulation (DBS) for patients with advanced symptoms not controlled by medication.
  3. Physical Therapy:

    • To improve mobility, balance, and flexibility.
  4. Occupational Therapy:

    • To assist with daily living activities.
  5. Speech Therapy:

    • To address speech and swallowing difficulties.
Demo Ad
This is a sample ad placement!

Thank you for reading from Firsthope's notes, don't forget to check YouTube videos!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.